Peer Review History
| Original SubmissionDecember 30, 2024 |
|---|
|
Dear Dr. Sigit, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ammal Mokhtar Metwally, Ph.D (MD) Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating in your Funding Statement: “This study is supported by the Indonesia Endowment Fund for Education (Indonesian: Lembaga Pengelola Dana Pendidikan; LPDP), Grant Number: NKB-696/UN2.RST/HKP.05.00/2021 PRIME (Partnership in Research Indonesia and Melbourne). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.” Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. We notice that your supplementary tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The manuscript is neat and well prepared, I would have only suggested that the discussion may need to be summarized little bit as there are many details from the results are repeated here, it may be better to point out the important findings and dirrectly connect that with other studies. Some sentences like this "We observed that around 15.1%-24.1% of the general public appeared to have insufficient knowledge" need to be corrected, instead of "general public" it is suitable to say "study population". At the abstract you mentioned " Men exhibited higher ignorance rates (34.2%, 35.2%, 23.2%) than women (10.7%, 12.9%, 7.0%).", I would suggest that the you change the word "ignorance" as this difinition is broad and cannot be determined subject wise. May be you could use "less knowledgable to the subject matter..." Reviewer #2: the study explores the effectiveness of community based surveillance system for maternal and child health in Depok, Indonesia. The methods used in the study appear to be appropriate and well suited for the research objectives. The mixed-method approach allows for the collection of broad statistical data and in-depth insights from stakeholders. The findings are beneficial for the improvement of the already established community health services in Indonesia. Reviewer #3: Title - Barriers and Opportunities in Developing Community-Based Maternal and Child Health Surveillance: A Mixed Methods Study in Depok, Indonesia The title is appropriate Abstract – Abstract is well structured but the section sub-titled as “Discussion” should be changed to “Conclusion”. Key words provided Introduction – Statement of problem is well written. The magnitude of the problem, rationale for the study and study objectives are well presented. Methods – The specific name of the study design is not mentioned. What is mentioned is the approach. This appears to be a descriptive cross-sectional study with a mixed methods approach. • Study setting is well described. • The minimum sample size estimation for the quantitative part of the study not calculated. appropriately written. • What type of random selection was used to select the households? • Data collection and analysis are well written • Provide information on the number of interviews and FGDs conducted. Result – the findings are fairly well presented. • …….. disproportionately higher in men (34.2%) than women (10.7%). - Is this difference found to be statistically significant? This should be analysed • ……… disproportionate proportion between men (35.2%) and women (12.9%). - Is this difference found to be statistically significant? This should be analysed • The qualitative findings should be improved upon by inserting some appropriate quotes in the various sub-themes even though this is on table 3. Discussion – Findings fairly well discussed. There is no conclusion section after the discussion. The study limitations were not mentioned. References - adequate ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Rukhsana Ahmed, MD, PhD; Epidemiologist Reviewer #3: Yes: Prof. Tanimola Makanjuola Akande ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 1 |
|
Dear Dr. Sigit, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Ammal Mokhtar Metwally, Ph.D (MD) Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Thank you for your resubmission of the manuscript entitled “Barriers and Opportunities in Developing Community-Based Maternal and Child Health Surveillance: A Mixed Methods Study in Depok, Indonesia.” We appreciate the thoughtful and comprehensive revisions you have made in response to reviewer feedback. Upon further editorial review, we find your manuscript significantly improved and of potential value to public health professionals, particularly in resource-limited contexts. The integration of both quantitative and qualitative data, along with an emphasis on real-world application, is commendable. However, a few remaining issues must be addressed before final acceptance. 1. Clarify and streamline the abstract • The abstract is informative but could benefit from improved clarity and brevity. • Certain terms such as “contrariwise” are less common in scientific writing and may hinder accessibility. • Replace “contrariwise” with “alternatively” and consider condensing long sentences for improved readability. 2. Refine discussion of results • The discussion section contains repetition of results. While referencing findings is useful, repeating detailed data limits space for deeper interpretation and policy relevance. • Instead of repeating knowledge percentages from the Results, use this space to propose how these gaps should inform health education initiatives. 3. Deepen policy implications in the conclusion • The conclusion provides practical recommendations, but could be more action-oriented. A well-articulated roadmap strengthens the utility of the findings for policymakers and health system planners. • Suggest launching a pilot community surveillance initiative integrating digital tools, with evaluation benchmarks based on this study. 4. Enhance transparency of qualitative insights • Although direct quotes have been added, representation of voices could be more balanced. Quotes are largely from officials or volunteers, with limited insights from family/community members. • Consider incorporating more quotes from mothers or household heads to reflect end-user perspectives. 5. Language and terminology refinement • Some phrases may benefit from more precise or neutral terminology. Terms like “ignorance rates” (now corrected) and “exclusive neighborhoods” could be rephrased for neutrality and clarity. • Use “less knowledgeable” instead of “ignorant,” and “gated communities” or “higher-income areas” instead of “exclusive neighborhoods.” 6. Reference formatting and integration • Citations are appropriate, but integration in the narrative could be smoother. Over reliance on parenthetical citation disrupts narrative flow. • Use phrases such as “as shown by Sharma et al. (2023)” instead of placing multiple bracketed references at the sentence end. 7. Supplemental material referencing • Supplemental tables provide valuable data but are not always clearly referenced in the main text. Cross-referencing enhances reader navigation and data transparency. • Add phrases like “(see Supplemental Table 2)” directly after discussing survey items. Final Comments: Your manuscript has undergone meaningful improvement in response to previous reviewer suggestions. The addition of statistical significance tests, a dedicated conclusion, and clearer methodological explanations have substantially improved the manuscript’s quality. With minor revisions primarily around clarity, structure, and terminology, the manuscript will be well-positioned for publication. We appreciate your contribution to advancing maternal and child health systems, especially in underserved settings. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors have satisfactory addressed most of my previous recomendations, but I am not still confissed the flow of the discussion part. You don't have to mention study aim again in here to start with, at the disscussion just mention your main findings, first finding and you interpretation flowed by comparing other studies. I would sugest to flow a clear line of presentation: 1.Your study results, two to three main findings 2. You can compare other studies to each point or as you did now mention all findings and then comparing the other studies to the equavalent finding. 3. Mention your limitations here. 3. Make your recommendations here or in the conclussion part at last section, not in the middle of the discussion as you mentioned in L366. Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Abdulkadir Ismael Ahmed Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Barriers and Opportunities in Developing Community-Based Maternal and Child Health Surveillance: A Mixed Methods Study in Depok, Indonesia PONE-D-24-59311R2 Dear Dr. Sigit, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ammal Mokhtar Metwally, Ph.D (MD) Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewer #1: Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: The authors have addressed all the comments made in the previous reviews, and I can confidently say that this article is nearly complete, requiring only a few minor adjustments. First, out of the 10 quotes mentioned in the results, only one is from community members. Since you have the data, I suggest incorporating more quotes from the community to enhance the representation. The discussion section has improved significantly but still feels a bit bulky due to repetitive sentences and paragraphs. I believe the discussion text could be trimmed by half while maintaining the content, making it more concise and easier to read. For instance, instead of listing all findings in a long paragraph (like in line 348), you could directly present your first finding and then transition with statements like, "This is consistent with..." or "In contrast, another study..." Additionally, the phrase "Comparing our results with other studies" is used repeatedly, which isn't necessary. You could simply connect your findings to other studies without restating the comparison. There is a minor grammatical error in line 376, but it should be resolved with the final adjustments. Also, in line 366, consider connecting the sentences, as the first sentence currently stands alone and requires its own reference. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Abdulkadir Ismael Ahmed ********** |
| Formally Accepted |
|
PONE-D-24-59311R2 PLOS ONE Dear Dr. Sigit, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Ammal Mokhtar Metwally Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .